Spillover adherence effects of fixed-dose combination HIV therapy

The impact of fixed-dose combination (FDC) products on adherence to other, non-fixed regimen components has not been examined. We compared adherence to a third antiretroviral (ART) component among patients receiving a nucleoside reverse transcriptase inhibitor (NRTI) backbone consisting of the FDC E...

Descripción completa

Detalles Bibliográficos
Autores principales: Kauf, Teresa L, Davis, Keith L, Earnshaw, Stephanie R, Davis, E Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295624/
https://www.ncbi.nlm.nih.gov/pubmed/22399848
http://dx.doi.org/10.2147/PPA.S28482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295624/
https://www.ncbi.nlm.nih.gov/pubmed/22399848
http://dx.doi.org/10.2147/PPA.S28482

Ejemplares similares